Skip to main content
SpringerLink
Log in

Fluorescein and fluorescein glucuronide in the vitreous body of diabetic patients

  • Original Investigations
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Fluorescein (F) and fluorescein glucuronide (FG) were determined in the vitreous of four diabetic patients by a double-filter slit-lamp fluorophtometric technique. Determinations were performed 60–80 min after i.v. injection of fluorescein. F and FG were also determined in plasma ultrafiltrate 5, 15, 30, 60 and 120 min after injection by high-pressure liquid chromatography. The concentration of FG in the vitreous was 3 times that of F. After correction for plasma concentrations of FG higher than those of F, the penetration index of FG through the blood-retinal barrier was found to be twice the penetration index of F. This is not what would be expected if passive transport alone were involved. Accordingly, it is suggested that active transport mechanisms contribute to the movement of F and FG across the blood-retinal barrier.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Best JA van, Vrij L, Oosterhuis JA (1985) Lens transmission of blue-green light in diabetic patients as measured by autofluorophotometry. Invest Ophthalmol Vis Sci 26:532–536

    Google Scholar 

  • Blair NP, Evans MA, Lesar TS, Zeimer RC (1986) Fluorescein and fluorescein glucuronide pharmacokinetics after intravenous injection. Invest Ophthalmol Vis Sci 27:1107–1114

    Google Scholar 

  • Bursell S-E, Delori FC, Yoshida A (1982) Instrument characterisation for vitreous fluorophotometry. Curr Eye Res 1:711–716

    Google Scholar 

  • Chahall PS, Neal MJ, Kohner EM (1985a) Metabolism of fluorescein after intravenous administration. Invest Ophthalmol Vis Sci 26:764–768

    Google Scholar 

  • Chahall PS, Chowienczyk PJ, Kohner EM (1985b) Measurement of blood-retinal barrier permeability: a reproducibility study in normal eyes. Invest Ophthalmol Vis Sci 26:977–982

    Google Scholar 

  • Chen S-C, Nakamura H, Tamura Z (1980a) Studies on the metabolites of fluorescein in rabbit and human urine. Chem Pharm Bull (Tokyo) 28:1403–1407

    Google Scholar 

  • Chen S-C, Nakamura H, Tamura Z (1980b) Determination of fluorescein and fluorescein monoglucuronide excreted in urine. Chem Pharm Bull (Tokyo) 28:2812–2816

    Google Scholar 

  • Cunha-Vaz JG, Abreu JF, Campos AJ, Figo GM (1975) Early breakdown of the blood-retinal barrier in diabetes. Br J Ophthalmol 59:649–656

    Google Scholar 

  • Grotte D, Mattow V, Brubaker R (1985) Fluorescent, physiological and pharmacokinetic properties of fluorescein glucuronide. Exp Eye Res 40:23–33

    Google Scholar 

  • Krogsaa B, Fledelius H, Larsen J, Lund-Andersen H (1984a) Photometric oculometry. I. An analysis of the optical principles in slit-lamp fluorophotometry. Acta Ophthalmol (Copenh) 62:274–289

    Google Scholar 

  • Krogsaa B, Fledelius H, Larsen J, Lund-Andersen H (1984b) Photometric oculometry. II. Measurement of axial ocular distances with slit-lamp microscopy. Clinical evaluation, and comparison with ultrasonography. Acta Ophthalmol (Copenh) 62:290–299

    Google Scholar 

  • Lund-Andersen H, Krogsaa B, la Cour M, Larsen J (1985) Quantitative vitreous fluorophotometry applying a mathematical model of the eye. Invest Ophthalmol Vis Sci 26:698–710

    Google Scholar 

  • McLaren JW, Brubaker RF (1986) Measurement of fluorescein and fluorescein monoglucuronide in the living human eye. Invest Ophthalmol Vis Sci 27:966–974

    Google Scholar 

  • Plehwe WE, Chahal PS, Fallon TJ, Neal M, Cunningham J, Kohner EM (1986) Fluorescein glucuronide does not significantly affect vitreous fluorescence (Abstract). Third symposium of the international society of ocular fluorophotometry, Florence, May 1, 1986

  • Zeimer RC, Cunha-Vaz JG, Johnson ME (1982) Studies on the technique of vitreous fluorophotometry. Invest Ophthalmol Vis Sci 22:668–674

    Google Scholar 

  • Zeimer RC, Blair NP, Cunha-Vaz JG (1983a) Vitreous fluorophotometry for clinical research. I. Description and evaluation of a new fluorophotometer. Arch Ophthalmol 101:1753–1756

    Google Scholar 

  • Zeimer RC, Blair NP, Cunha-Vaz JG (1983b) Vitreous fluorophotometry for clinical research. II. Method of data acquisition and processing. Arch Ophthalmol 101:1757–1761

    Google Scholar 

  • Zeimer RC, Noth JM (1984) A new method of measuring in vivo the lens transmittance, and study of lens scatter, fluorescence and transmittance. Ophthalmic Res 16:246–255

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University Eye Department, Gentofte Hospital, Ø 404, DK-2900, Hellerup, Copenhagen, Denmark

    H. Lund-Andersen, M. Larsen, P. Dalgaard & W. Olsen

Authors
  1. H. Lund-Andersen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Larsen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Dalgaard
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. W. Olsen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lund-Andersen, H., Larsen, M., Dalgaard, P. et al. Fluorescein and fluorescein glucuronide in the vitreous body of diabetic patients. Graefe's Arch Clin Exp Ophthalmol 225, 173–176 (1987). https://doi.org/10.1007/BF02175445

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02175445

Keywords

Search

Navigation